Hookipa Pharma Inc Quick Ratio (HOOK) starting from the first quarter 2025 to first quarter 2024, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Hookipa Pharma inc   (NASDAQ: HOOK)

Hookipa Pharma Inc 's Quick Ratio

HOOK's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Hookipa Pharma Inc 's Cash & cash equivalent grew by 1.49 % in the Q1 2025 sequentially, while Current Liabilities decreased, this led to improvement in Hookipa Pharma Inc 's Quick Ratio to 2.42, Quick Ratio remained below Hookipa Pharma inc average.

Within Major Pharmaceutical Preparations industry 230 other companies have achieved higher Quick Ratio than Hookipa Pharma Inc in first quarter 2025. While Quick Ratio total ranking has improved so far during the Q1 2025 to 822, from total ranking in the fourth quarter 2024 at 1078.

Explain Quick Ratio?
How much Cash & cash equivalents HOOK´s has?
What are HOOK´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

HOOK Quick Ratio (Mar 31 2025)
Q1		 (Dec 31 2024)
Q4		 (Sep 30 2024)
Q3		 (Jun 30 2024)
Q2		 (Mar 31 2024)
Q1
Y / Y Current Liabilities Change -43.62 % -49.1 % -29.59 % -39.81 % -33.25 %
Y / Y Cash & cash equivalent Change -56.58 % -66.11 % -44.51 % -43.1 % -15.37 %
Quick Ratio MRQ 2.42 1.61 2.09 2.77 3.14
HOOK's Total Ranking # 822 # 1078 # 917 # 549 # 509
Seq. Current Liabilities Change -32.52 % -13.7 % 2.64 % -5.67 % -39.07 %
Seq. Cash & cash equivalent Change 1.49 % -33.58 % -22.55 % -16.82 % -20.79 %



Quick Ratio first quarter 2025 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 231
Healthcare Sector # 396
Overall Market # 822


Quick Ratio Statistics
High Average Low
35.46 5.3 1.61
(Sep 30 2019)   (Dec 31 2024)




Financial Statements
Hookipa Pharma Inc 's Current Liabilities $ 17 Millions Visit HOOK's Balance sheet
Hookipa Pharma Inc 's Cash & cash equivalent $ 40 Millions Visit HOOK's Balance sheet
Source of HOOK's Sales Visit HOOK's Sales by Geography


Cumulative Hookipa Pharma Inc 's Quick Ratio

HOOK's Quick Ratio for the trailling 12 Months

HOOK Quick Ratio

 (Mar 31 2025)
12 Months		 (Dec 31 2024)
12 Months		 (Sep 30 2024)
12 Months		 (Jun 30 2024)
12 Months		 (Mar 31 2024)
12 Months
Y / Y Current Liabilities TTM Growth -40.71 % -38.39 % -19.39 % -3.81 % 23.77 %
Y / Y Cash & cash equivalent TTM Growth -52.14 % -42.69 % -25.49 % -13.72 % 3.03 %
Quick Ratio TTM 2.22 2.44 2.58 2.7 2.75
Total Ranking TTM # 3892 # 3418 # 689 # 3220 # 2192
Seq. Current Liabilities TTM Growth -11.64 % -17.7 % -8.21 % -11.17 % -8.19 %
Seq. Cash & cash equivalent TTM Growth -19.48 % -22.33 % -12.14 % -12.9 % -3.59 %

Quick ratio ranking by company, industry and sector >> Back to HOOK Financial Strength Comparisons >> Go to Compare HOOK Quick Ratio to its Competitors

On the trailing twelve months basis In spite of the year on year decrease in HOOK's Current Liabilities to $16.64 millions, cumulative Quick Ratio to 2.22 below the HOOK average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 484 other companies have achieved higher Quick Ratio than Hookipa Pharma Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the fourth quarter 2024 from 3418 to 3892.

Explain Quick Ratio?
How much Cash & cash equivalents HOOK´s has?
What are HOOK´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 485
Healthcare Sector # 980
Within the Market # 3892


trailing twelve months Quick Ratio Statistics
High Average Low
7.04 3.78 1.27
(Jun 30 2020)   (Sep 30 2019)




Companies with similar Quick Ratio in the quarter ending Mar 31 2025, within Major Pharmaceutical Preparations Industry Quick RatioMar 31 2025 MRQ Cash & cash equivalentMar 31 2025 MRQ Current Liabilities
Sensei Biotherapeutics Inc   6.57 $ 34.331  Millions$ 5.229  Millions
Lipella Pharmaceuticals Inc   6.50 $ 4.225  Millions$ 0.650  Millions
Kalvista Pharmaceuticals Inc   6.49 $ 220.617  Millions$ 33.983  Millions
Metsera Inc   6.48 $ 588.335  Millions$ 90.741  Millions
Zentalis Pharmaceuticals Inc   6.48 $ 320.302  Millions$ 49.430  Millions
Galmed Pharmaceuticals Ltd   6.38 $ 18.156  Millions$ 2.845  Millions
Vistagen Therapeutics Inc   6.38 $ 80.482  Millions$ 12.612  Millions
Zenas Biopharma Inc   6.36 $ 312.379  Millions$ 49.132  Millions
Silence Therapeutics Plc  6.33 $ 157.283  Millions$ 24.843  Millions
Cybin Inc   6.30 $ 103.427  Millions$ 16.406  Millions
Alzamend Neuro Inc   6.22 $ 3.949  Millions$ 0.635  Millions
Amarin Corp Plcuk  6.18 $ 282.087  Millions$ 45.661  Millions
Tango Therapeutics Inc   6.03 $ 216.724  Millions$ 35.917  Millions
Oramed Pharmaceuticals Inc  5.72 $ 30.396  Millions$ 5.311  Millions
Puretech Health Plc  5.59 $ 258.842  Millions$ 46.309  Millions
Marker Therapeutics inc   5.47 $ 13.693  Millions$ 2.501  Millions
Syndax Pharmaceuticals Inc   5.46 $ 516.313  Millions$ 94.551  Millions
Lava Therapeutics Nv  5.46 $ 106.274  Millions$ 19.468  Millions
Nucana Plc  5.43 $ 34.978  Millions$ 6.445  Millions
Ovid Therapeutics Inc   5.41 $ 42.996  Millions$ 7.947  Millions
Igm Biosciences Inc   5.39 $ 152.112  Millions$ 28.198  Millions
Gossamer Bio Inc   5.35 $ 257.934  Millions$ 48.223  Millions
Immutep Limited  5.28 $ 44.307  Millions$ 8.386  Millions
Longeveron Inc   5.26 $ 14.327  Millions$ 2.724  Millions
Alx Oncology Holdings Inc  5.22 $ 97.831  Millions$ 18.742  Millions
Bio Green Med Solution Inc   5.20 $ 3.450  Millions$ 0.663  Millions
Catalyst Pharmaceuticals Inc   5.20 $ 580.656  Millions$ 111.649  Millions
Arcus Biosciences Inc   5.19 $ 997.000  Millions$ 192.000  Millions
Relmada Therapeutics Inc  5.17 $ 27.061  Millions$ 5.231  Millions
Vireo Growth Inc.  5.15 $ 86.261  Millions$ 16.738  Millions

Date modified: 2026-09-26T07:38:36+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.